Transcending Self Therapy in the treatment of Alcohol Use Disorder

Skupinová terapia sebapresiahnutím (TS) je novým psychoterapeutickým prístupom navrhnutým pre liečbu závislostí, vychádzajúcim z kognitívno-behaviorálnej terapie. Cieľom práce bolo porovnať účinnosť TS s obvyklou psychoterapeutickou liečbou (OL) u pacientov vstupujúcich do ambulantnej liečby kvôli závislosti od alkoholu. Štúdie sa zúčastnilo 79 participantov (33 % žien) s priemerným vekom 46,8 rokov (SD = 12,5). Pacientom bola poskytnutá buď TS (n = 39) alebo OL (n = 40). Skupiny boli porovnávané v miere relapsu, v retencii v liečbe, v miere psychopatológie a v kvalite života. Po 20 týždňoch liečby neboli zistené rozdiely v účinnosti liečby medzi TS a OL. O výsledkoch štúdie diskutujeme cez optiku známych faktorov ovplyvňujúcich účinnosť psychoterapie.Group Transcending Self Therapy (TST) is a new psychotherapeutic approach designed for the treatment of addictions, based on cognitive-behavioural therapy. The aim of the study was to compare the effectiveness of this approach with the treatment as usual (TAU) in patients entering outpatient treatment for alcohol use disorder. The study involved 79 participants (33% women) with a mean age of 46.8 years (SD = 12.5). Patients were provided with either TST (n = 39) or TAU (n = 40). The groups were compared in terms of relapse rate, retention in treatment, level of psychopathology and quality of life. After 20 weeks of treatment, there were no differences in treatment efficacy between TST and TAU. We discuss the results of the study through the optics of known factors influencing the effectiveness of psychotherapy

Opioid agonist maintenance treatment outcomes : the OPTIMUS international consensus towards evidence-based and patient-centred care, an interim report

Abstract: Non-medical opioid use is a major public health concern causing high mortality. While opioid agonist maintenance treatment (OMT) is a key life-saving intervention, there is (a) no international consensus on opioid treatment outcomes and (b) few opioid treatment outcome studies include key (public) health outcomes, such as overdose or HIV/hepatitis C. We report the rationale and study protocol for, and preliminary results of, an on-going international OMT outcomes consensus study that aims to address this double gap (n= 110 collaborating experts from 32 countries, plus a n = 477 Delphi evaluation panel from 26 of those countries: 58% male, 41% female; 47% OMT patients, 53% OMT professionals). We present a first draft of a patient interview guide (including a \u2018clinical form\u2019) to monitor OMT outcomes in six domains. The form appears to be well accepted and feasible in early testing. Through this, we aim to enhance the quality of and access to OMT and improve the survival, health, and quality of life of people who use opioids, while promoting nonstigmatising patient-physician relationships